Engineering of factor H binding protein, a key vaccine antigen for the prevention of meningococcal disease

被引：0
|
作者：
Lavender, Hayley [1 ]
Lea, Susan [1 ]
Tang, Christoph [1 ]
机构：
[1] Univ Oxford, Oxford OX1 2JD, England
来源：
NEW BIOTECHNOLOGY | 2014年 / 31卷
关键词：
D O I：
10.1016/j.nbt.2014.05.1763
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
O17-2
引用
收藏
页码：S66 / S66
页数：1
相关论文
共 50 条
  • [1] Defining a protective epitope on factor H binding protein, a key meningococcal virulence factor and vaccine antigen
    Malito, Enrico
    Faleri, Agnese
    Lo Surdo, Paola
    Veggi, Daniele
    Maruggi, Giulietta
    Grassi, Eva
    Cartocci, Elena
    Bertoldi, Isabella
    Genovese, Alessia
    Santini, Laura
    Romagnoli, Giacomo
    Borgogni, Erica
    Brier, Sebastien
    Lo Passo, Carla
    Domina, Maria
    Castellino, Flora
    Felici, Franco
    van der Veen, Stijn
    Johnson, Steven
    Lea, Susan M.
    Tang, Christoph M.
    Pizza, Mariagrazia
    Savino, Silvana
    Norais, Nathalie
    Rappuoli, Rino
    Bottomley, Matthew J.
    Masignani, Vega
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (09) : 3304 - 3309
  • [2] Meningococcal factor H binding protein as immune evasion factor and vaccine antigen
    Principato, Silvia
    Pizza, Mariagrazia
    Rappuoli, Rino
    FEBS LETTERS, 2020, 594 (16) : 2657 - 2669
  • [3] Factor H-binding protein, a unique meningococcal vaccine antigen
    Pizza, Mariagrazia
    Donnelly, John
    Rappuoli, Rino
    VACCINE, 2008, 26 : I46 - I48
  • [4] Does Binding of Complement Factor H to the Meningococcal Vaccine Antigen, Factor H Binding Protein, Decrease Protective Serum Antibody Responses?
    Granoff, Dan M.
    Ram, Sanjay
    Beernink, Peter T.
    CLINICAL AND VACCINE IMMUNOLOGY, 2013, 20 (08) : 1099 - 1107
  • [5] Neisseria meningitidis factor H-binding protein fHbp: a key virulence factor and vaccine antigen
    Seib, Kate L.
    Scarselli, Maria
    Comanducci, Maurizio
    Toneatto, Daniela
    Masignani, Vega
    EXPERT REVIEW OF VACCINES, 2015, 14 (06) : 841 - 859
  • [6] Impaired Immunogenicity of a Meningococcal Factor H-Binding Protein Vaccine Engineered To Eliminate Factor H Binding
    Beernink, Peter T.
    Shaughnessy, Jutamas
    Ram, Sanjay
    Granoff, Dan M.
    CLINICAL AND VACCINE IMMUNOLOGY, 2010, 17 (07) : 1074 - 1078
  • [7] NEW PROTEIN VACCINE FOR PREVENTION OF MENINGOCOCCAL DISEASE
    KENNY, CP
    JENNINGS, HJ
    CALVER, GA
    CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE, 1978, 69 (01): : 71 - 71
  • [8] Meningococcal Factor H Binding Protein Vaccine Antigens with Increased Thermal Stability and Decreased Binding of Human Factor H
    Rossi, Raffaella
    Konar, Monica
    Beernink, Peter T.
    INFECTION AND IMMUNITY, 2016, 84 (06) : 1735 - 1742
  • [9] Two human antibodies to a meningococcal serogroup B vaccine antigen enhance binding of complement Factor H by stabilizing the Factor H binding site
    Sands, Nathaniel A.
    Beernink, Peter T.
    PLOS PATHOGENS, 2021, 17 (06)
  • [10] Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease
    Jiang, Han-Qing
    Hoiseth, Susan K.
    Harris, Shannon L.
    McNeil, Lisa K.
    Zhu, Duzhang
    Tan, Cuiwen
    Scott, Adrienne A.
    Alexander, Kristin
    Mason, Kathryn
    Miller, Lynn
    DaSilva, Ida
    Mack, Michelle
    Zhao, Xiao-Juan
    Pride, Michael W.
    Andrew, Lubomira
    Murphy, Ellen
    Hagen, Michael
    French, Roger
    Arora, Ashoni
    Jones, Thomas R.
    Jansen, Kathrin U.
    Zlotnick, Gary W.
    Anderson, Annaliesa S.
    VACCINE, 2010, 28 (37) : 6086 - 6093
12345